NurExone Biologic Aktie - J90

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,392

Gebot

0,37

Fragen

0,414

Volumen

19.600

0,366 Tagesbereich 0,398

0,29 52-Wochen-Bereich 0,595

Handelsende

0,376

Handelsbeginn

0,388

Letzte Trade

300

0.398

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

36.044

Finanzvolumen

VWAP

NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award

TORONTO and HAIFA, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB:...

NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock

TORONTO and HAIFA, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB:...

NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation

TORONTO and HAIFA, Israel, Feb. 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB:...

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB:...

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB:...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.012	3.15789473684	0.38	0.414	0.336	35164	0.35462484	DE
4	-0.002	-0.507614213198	0.394	0.432	0.336	28188	0.38418513	DE
12	-0.133	-25.3333333333	0.525	0.53	0.336	36044	0.42011408	DE
26	0.01	2.61780104712	0.382	0.5799999	0.324	54641	0.45431261	DE
52	-0.048	-10.9090909091	0.44	0.595	0.2899999	66752	0.46029016	DE
156	0.242	161.333333333	0.15	0.92	0.15	97634	0.51388685	DE
260	0.242	161.333333333	0.15	0.92	0.15	97634	0.51388685	DE

J90 - Frequently Asked Questions (FAQ)

What is the current NurExone Biologic share price?

The current share price of NurExone Biologic is 0,392 €

What is the 1 year trading range for NurExone Biologic share price?

NurExone Biologic has traded in the range of 0,29 € to 0,595 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
E3O1Nexoptic Technology Corp	0,013 € (52,94%)	7,63k
VOPInvestigator Resources Ltd	0,0175 € (40,00%)	4,89k
IAHInternational Lithium Corp	0,0145 € (38,10%)	20,1k
K6SMira Pharmaceuticals Inc	1,20 € (37,93%)	3,67k
B5S0NU E Power Corp	0,283 € (36,06%)	76,19k
9COCorus Entertainment	0,0335 € (-43,70%)	460
C0MCCS Abwicklungs AG	0,08 € (-42,45%)	196,61k
47GAGo Metals Corp	0,0142 € (-36,61%)	4,13k
M0YNMynaric AG	0,866 € (-35,85%)	429,67k
WIG1Wige Media AG	0,017 € (-35,85%)	1,44M
D7GNel ASA	0,28 € (-11,81%)	36,74M
RQ0DWave Quantum Inc	6,384 € (19,95%)	3,19M
DRHDroneShield Limited	0,575 € (7,68%)	2,21M
DMLSayona Mining Limited	0,0115 € (-4,96%)	1,88M
WIG1Wige Media AG	0,017 € (-35,85%)	1,44M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NurExone Biologic Inc (J90)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

J90 Neueste Nachrichten

NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award

NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock

NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

NurExone Biologic Secures Master Cell Bank

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

J90 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

NurExone Biologic Inc (J90) Börsenkurse

NurExone Biologic Inc (J90)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

J90 Neueste Nachrichten

NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award

NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock

NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

NurExone Biologic Secures Master Cell Bank

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

J90 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen